HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emmanuel J Favaloro Selected Research

Platelet Glycoprotein GPIb-IX Complex (Glycoprotein Ib)

1/2017Utility of the von Willebrand factor collagen binding assay in the diagnosis of von Willebrand disease.
1/2017Laboratory Testing for von Willebrand Factor Activity by Glycoprotein Ib Binding Assays (VWF:GPIb).
6/2016Laboratory tests used to help diagnose von Willebrand disease: an update.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emmanuel J Favaloro Research Topics

Disease

57Thrombosis (Thrombus)
09/2022 - 02/2004
56Hemorrhage
11/2022 - 12/2005
48von Willebrand Diseases (von Willebrand's Disease)
10/2022 - 04/2002
27COVID-19
09/2022 - 01/2020
19Thrombocytopenia (Thrombopenia)
09/2022 - 10/2012
16Thrombophilia
01/2021 - 02/2005
14Activated Protein C Resistance (APC Resistance)
01/2021 - 08/2002
13Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
02/2022 - 02/2004
13Hemophilia A (Haemophilia)
02/2022 - 11/2004
12Neoplasms (Cancer)
03/2022 - 10/2004
12Venous Thromboembolism
01/2017 - 11/2005
11Venous Thrombosis (Deep-Vein Thrombosis)
01/2022 - 01/2007
9Inflammation (Inflammations)
11/2022 - 05/2007
9Cardiovascular Diseases (Cardiovascular Disease)
03/2019 - 11/2007
6Vascular System Injuries
09/2021 - 01/2010
6Type 2 von Willebrand Disease
04/2021 - 08/2007
5Disseminated Intravascular Coagulation
06/2020 - 01/2008
5Myocardial Infarction
01/2020 - 10/2009
5Pulmonary Embolism
11/2019 - 06/2008
5Hemolysis
10/2019 - 01/2011
4Acute Kidney Injury (Acute Renal Failure)
04/2022 - 07/2021
4Obesity
01/2022 - 11/2007
4Hemophilia B (Haemophilia B)
06/2020 - 07/2012
3Thrombotic Microangiopathies
01/2022 - 07/2021
3Infections
08/2021 - 02/2010
3Thrombotic Thrombocytopenic Purpura
01/2021 - 01/2018
3Wounds and Injuries (Trauma)
02/2013 - 02/2009
3Insulin Resistance
02/2010 - 11/2007
2Communicable Diseases (Infectious Diseases)
02/2022 - 01/2008
2Overweight
01/2022 - 09/2020
2Renal Insufficiency (Renal Failure)
01/2021 - 06/2020
2Acute-Phase Reaction
10/2020 - 12/2010
2Hypertension (High Blood Pressure)
09/2020 - 07/2010
2Critical Illness (Critically Ill)
04/2020 - 10/2008
2Vascular Diseases (Vascular Disease)
01/2020 - 07/2019
2Anemia
10/2019 - 07/2010
2Hyperbilirubinemia
10/2019 - 04/2013
2Hypertriglyceridemia
10/2019 - 04/2013
2Ischemic Stroke
03/2019 - 10/2012

Drug/Important Bio-Agent (IBA)

48von Willebrand FactorIBA
11/2022 - 04/2002
27AnticoagulantsIBA
11/2022 - 02/2005
23Heparin (Liquaemin)FDA LinkGeneric
11/2022 - 07/2006
23Biological ProductsIBA
09/2020 - 04/2002
16AntibodiesIBA
04/2022 - 02/2004
15fibrin fragment D (D-dimer)IBA
09/2022 - 01/2008
15Factor VIII (Coagulation Factor VIII)IBA
10/2020 - 06/2003
13Antiphospholipid AntibodiesIBA
02/2022 - 04/2008
13Blood Coagulation Factors (Coagulation Factor)IBA
02/2022 - 02/2005
11Protein CIBA
01/2021 - 08/2002
10Proteins (Proteins, Gene)FDA Link
11/2022 - 02/2009
10Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
02/2022 - 02/2005
10AntithrombinsIBA
01/2021 - 02/2005
10factor V LeidenIBA
01/2021 - 08/2002
9Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2008
9ThrombinFDA Link
10/2019 - 10/2004
9Blood Proteins (Serum Proteins)IBA
04/2017 - 01/2008
8Platelet Factor 4IBA
04/2022 - 07/2010
8Protein SIBA
01/2021 - 02/2005
8Hemostatics (Antihemorrhagics)IBA
10/2019 - 03/2007
8Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
04/2017 - 07/2006
7VaccinesIBA
09/2022 - 08/2021
7Prothrombin (Factor II)IBA
10/2019 - 02/2005
7Vitamin KFDA Link
03/2019 - 01/2008
6Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2022 - 11/2008
6Fibrinogen (Factor I)FDA Link
10/2020 - 10/2009
6Pharmaceutical PreparationsIBA
06/2020 - 07/2009
6CollagenIBA
01/2017 - 04/2002
5AntigensIBA
09/2022 - 12/2014
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2020 - 12/2010
5Warfarin (Coumadin)FDA LinkGeneric
02/2020 - 01/2007
5Thromboplastin (Tissue Factor)IBA
04/2013 - 10/2009
4COVID-19 VaccinesIBA
04/2022 - 08/2021
4C-Reactive ProteinIBA
02/2022 - 11/2007
4RistocetinIBA
12/2021 - 11/2007
4RivaroxabanIBA
01/2021 - 06/2015
4Fibrinolytic Agents (Antithrombotic Agents)IBA
07/2020 - 02/2011
4Factor V (Coagulation Factor V)IBA
01/2018 - 10/2004
3EnzymesIBA
02/2022 - 02/2004
3AutoantibodiesIBA
02/2022 - 07/2012
3apixabanIBA
01/2021 - 06/2015
3thiamine triphosphorate (TTP)IBA
01/2021 - 01/2018
3Oxygen (Dioxygen)IBA
11/2018 - 04/2011
3Platelet Glycoprotein GPIb-IX Complex (Glycoprotein Ib)IBA
01/2017 - 06/2016
3FibrinIBA
01/2016 - 11/2010
3ABO Blood-Group SystemIBA
07/2012 - 12/2005
3Antifibrinolytic Agents (Antifibrinolytics)IBA
05/2012 - 01/2007
2Lipoproteins (Lipoprotein)IBA
04/2022 - 02/2010
2Lipoprotein(a)IBA
04/2022 - 07/2019
2ImmunosorbentsIBA
02/2022 - 02/2004
2Serotonin (5 Hydroxytryptamine)IBA
08/2021 - 11/2007
2Indicators and Reagents (Reagents)IBA
01/2021 - 06/2020
2PRT064445IBA
01/2021 - 01/2020
2Tissue Plasminogen Activator (Alteplase)FDA Link
01/2021 - 02/2013
2Plasminogen Activators (Plasminogen Activator)IBA
01/2021 - 02/2013
2von Willebrand factor drug combination factor VIIIIBA
10/2020 - 01/2016
2TroponinIBA
10/2020 - 11/2019
2Dacarbazine (DIC)FDA LinkGeneric
06/2020 - 06/2010

Therapy/Procedure

47Therapeutics
10/2022 - 07/2006
2Critical Care (Surgical Intensive Care)
02/2022 - 01/2022
2Platelet Transfusion (Blood Platelet Transfusions)
04/2020 - 07/2009